Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:59-66

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumann, K. H.
Right arrow Articles by von Schacky, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumann, K. H.
Right arrow Articles by von Schacky, C.
Related Collections
Right arrow Pathophysiology
Right arrow Gene expression
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:59-66.)
© 1999 American Heart Association, Inc.


Original Contributions

Dietary {omega}-3, {omega}-6, and {omega}-9 Unsaturated Fatty Acids and Growth Factor and Cytokine Gene Expression in Unstimulated and Stimulated Monocytes

A Randomized Volunteer Study

Klaus H. Baumann; Franz Hessel; Iris Larass; Thomas Müller; Peter Angerer; Rosemarie Kiefl; Clemens von Schacky

From Medizinische Klinik, Klinikum Innenstadt, University of Munich, Munich, Germany.

Correspondence to Clemens von Schacky, MD, Medizinische Klinik, Klinikum Innenstadt, Universität München, Ziemssenstr 1, D-80336 Munich, Munich, Germany. E-mail vonschacky{at}medinn.med.uni-muenchen.de

Abstract—Dietary {omega}-3 fatty acids retard coronary atherosclerosis. Previously, we demonstrated that dietary {omega}-3 fatty acids reduce platelet-derived growth factor (PDGF)-A and PDGF-B mRNA levels in unstimulated, human mononuclear cells (MNCs). In a randomized, investigator-blinded intervention trial, we have now compared the effect of ingestion of 7 g/d {omega}-3, {omega}-6, or {omega}-9 fatty acids for 4 weeks versus no dietary intervention on PDGF-A, PDGF-B, heparin-bound epidermal growth factor (HB-EGF), monocyte chemoattractant protein-1 (MCP-1), and interleukin-10 gene expression in unstimulated MNCs and in monocytes that were adherence-activated ex vivo in a total of 28 volunteers. In unstimulated MNCs, mRNA steady-state levels of PDGF-A, PDGF-B, and MCP-1 were reduced by 25±10%, 31±13%, and 40±14%, respectively, after {omega}-3 fatty acid ingestion, as assessed by quantitative polymerase chain reaction (all P<0.05). In monocytes that were adherence-activated ex vivo for 4 and 20 hours, mRNA steady-state levels of PDGF-A, PDGF-B, and MCP-1 were reduced by 25±13%, 20±15%, and 30±8%, respectively (all P<0.05). Interleukin-10 and HB-EGF mRNA steady-state levels were not influenced by {omega}-3 fatty acid ingestion. Expression of all respective mRNAs in control volunteers or in those ingesting {omega}-6 or {omega}-9 fatty acids were not altered. We conclude that human gene expression for PDGF-A, PDGF-B, and MCP-1, factors thought relevant to atherosclerosis, is constitutive, is constant, and can be reduced only by dietary {omega}-3 fatty acids in unstimulated and adherence-activated monocytes.


Key Words: mRNA • platelet-derived growth factor • monocyte chemoattractant protein-1 • interleukin-10 • heparin-bound epidermal growth factor




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
U. J. Jung, C. Torrejon, A. P Tighe, and R. J Deckelbaum
n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 2003S - 2009S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. C. Calder
Immunological Parameters: What Do They Mean?
J. Nutr., March 1, 2007; 137(3): 773S - 780S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. J Deckelbaum, T. S Worgall, and T. Seo
n-3 Fatty acids and gene expression
Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1520 - 1525S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. S Kornman
Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 475S - 483S.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Macchia, G. Levantesi, M. G. Franzosi, E. Geraci, A. P. Maggioni, R. Marfisi, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, et al.
Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids
Eur J Heart Fail, August 1, 2005; 7(5): 904 - 909.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Angerer, W. Kothny, S. Stork, and C. von Schacky
Effect of dietary supplementation with {omega}-3 fatty acids on progression of atherosclerosis in carotid arteries
Cardiovasc Res, April 1, 2002; 54(1): 183 - 190.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Stork, K. Baumann, C. von Schacky, and P. Angerer
The effect of 17{beta}-estradiol on MCP-1 serum levels in postmenopausal women
Cardiovasc Res, February 15, 2002; 53(3): 642 - 649.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. von Schacky
n-3 Fatty acids and the prevention of coronary atherosclerosis1
Am. J. Clinical Nutrition, January 1, 2000; 71(1): 224S - 227S.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. von Schacky, P. Angerer, W. Kothny, K. Theisen, and H. Mudra
The Effect of Dietary {omega}-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Ann Intern Med, April 6, 1999; 130(7): 554 - 562.
[Abstract] [Full Text] [PDF]